YKL-40 is a secreted glycoprotein that has been described as a diagnostic and prognostic marker for a number of cancers including epithelial ovarian cancer. In this study, we examined the frequency of its serum elevation in patients with postmenopausal bleeding and thickened endometrium for its possible use in assessment of endometrial pathologies as atypical hyperplasia and malignancy.